Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells
Cardiovascular disease incidence continues to rise and new treatment paradigms are warranted. We reported previously that activation of Angiotensin II receptor (encoded by the X-linked Agtr2 gene) by a new peptide agonist, NP-6A4, was more effective in protecting mouse cardiomyocyte HL-1 cells and h...
Saved in:
Main Authors: | Ryan Toedebusch (Author), Anthony Belenchia (Author), Lakshmi Pulakat (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4
by: Madhavi P. Gavini, et al.
Published: (2021) -
Angiotensin Type 2 Receptors: Painful, or Not?
by: Lakshmi Pulakat, et al.
Published: (2020) -
Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy
by: Lakshmi Pulakat, et al.
Published: (2020) -
Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells
by: Haiyan Yang, et al.
Published: (2022) -
Signal Transduction and Smooth Muscle
Published: (2019)